Wed, Apr 23, 8:50 PM (25 days ago)
### Summary of BIO-key International, Inc. (BKYI) **Financial Performance:** - **Revenue:** $6,929,571 in 2024, down 11% from $7,754,905 in 2023. - **Net Loss:** $(4,300,692) in 2024, improved from $(8,521,837) in 2023. - **Gross Profit:** $5,640,186 in 2024, up from $1,431,319 in 2023. - **Operating Expenses:** $9,651,227 in 2024, up from $10,257,636 in 2023. - **Earnings per Share (EPS):** $(2.09) in 2024, improved from $(15.21) in 2023. **Strategic Overview:** - **Market Focus:** Enterprise IAM, government services, highly-regulated industries. - **Growth Strategy:** Increased marketing, large-scale identification projects, channel alliance program, strategic acquisitions. - **Future Outlook:** Continued growth in IAM market, expansion into new verticals, improved financial condition. **Risk Factors:** - **Financial Risks:** History of losses, negative cash flow, dependence on debt and equity financing. - **Operational Risks:** Competition, rapid technological change, integration of acquisitions. - **Market Risks:** Dependence on key employees, intellectual property protection, regulatory compliance. **Financial Condition:** - **Cash and Cash Equivalents:** $437,604 in 2024, down from $511,400 in 2023. - **Liquidity:** Requires approximately $812,000 per month to conduct operations. - **Capital Resources:** Financed through debt and equity, factoring receivables. **Market Position Changes:** - **Stock Performance:** Trading on Nasdaq Capital Market under the symbol "BKYI". - **Shareholders:** 170 stockholders of record as of April 21, 2025. - **Dividends:** No cash dividends paid or planned. **Note:** All amounts are in thousands ($000s) unless otherwise specified.